Related Experiment Video

Updated: Dec 31, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.0K

Metabolic Reprogramming and Vulnerabilities in Cancer

Costas A Lyssiotis1,2,3, Deepak Nagrath4,5,6

  • 1Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.

Cancers
|January 8, 2020
PubMed

Insights

Tumors rewire metabolic programs for growth and immune evasion. This research explores metabolic reprogramming in cancer, including cell interactions and immune system impacts, highlighting vulnerabilities.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Tumor Microenvironment Immunology

Background:

  • Cancer cells reprogram metabolic pathways to fuel rapid growth, survival, and evade immune surveillance.
  • Signaling pathways activated by oncogenes and loss of tumor suppressors drive these metabolic alterations.
  • Recent research investigates metabolic crosstalk between diverse tumor-infiltrating cells.

Discussion:

  • Metabolic reprogramming within tumors supports cancer progression and immune evasion.
  • Interactions among heterogeneous cell populations in the tumor microenvironment significantly influence cancer immunity.
  • Understanding these complex metabolic networks is crucial for developing novel cancer therapies.

Key Insights:

  • Deregulated metabolic programming presents unique vulnerabilities exploitable for cancer treatment.
  • Cancer cell metabolism is intrinsically linked to the tumor immune landscape.
  • Intercellular metabolic dependencies within tumors can be targeted therapeutically.

Outlook:

  • Future research will focus on targeting metabolic vulnerabilities in cancer.
  • Developing strategies to modulate tumor metabolism could enhance immunotherapy efficacy.
  • Further exploration of tumor-cell metabolic interactions may reveal new therapeutic targets.
Keywords:
amino acidscancer associated fibroblastscancer metabolismcarbohydratesironlipidsnucleotidesreactive oxygen speciesredoxtumor microenvironment

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.3K
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

990

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K